Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy

Area of Science:

• Molecular Biology
• Cellular Biology
• Physiology

Background:

• Skeletal muscle atrophy involves decreased protein synthesis and increased protein breakdown via ubiquitin-proteasome system and autophagy.
• FoxO transcription factors upregulate genes like MAFbx, initiating protein degradation during atrophy.
• Histone deacetylase 6 (HDAC6) interacts with the ubiquitin-proteasome system.

Purpose of the Study:

• To investigate the role of HDAC6 in skeletal muscle atrophy.
• To determine if HDAC6 is a downstream target of FoxO3a in muscle stress response.
• To explore HDAC6 as a potential therapeutic target for muscle wasting.

Main Methods:

• Analysis of HDAC6 expression during muscle atrophy.
• Investigating the transcriptional regulation of HDAC6 by FoxO3a.
• Assessing the effect of HDAC6 inactivation on muscle wasting in mice.
• Examining the interaction between HDAC6 and MAFbx.

Main Results:

• HDAC6 expression is increased during muscle atrophy.
• HDAC6 activation is dependent on the transcription factor FoxO3a.
• Inactivation of HDAC6 protects mice against muscle wasting.
• HDAC6 interacts with MAFbx, a key ubiquitin ligase in muscle atrophy.

Conclusions:

• HDAC6 plays a significant role in skeletal muscle wasting.
• HDAC6 is identified as a novel downstream target of FoxO3a in stress response.
• HDAC6 represents a potential biomarker and therapeutic target for muscle atrophy.